Stockholm, Sweden

ESTRO 2026

Local time in host city

Programme

10 Sessions
Sunday
May 17
15:15 - 16:30
A1 Plenary
Ananya Choudhury, United Kingdom;
Paul Sargos, France
Symposium
Clinical
Sunday
May 17
15:15 - 16:30
A3
Philippe Pereira, Germany;
Thomas Brunner, Austria
Symposium
Clinical
Sunday
May 17
15:15 - 16:30
A7
David Thwaites, United Kingdom;
Leah McDermott, Australia;
Marion Essers, The Netherlands
4m EIVD definition, current methods and adoption 4m Limiting factors for the widespread clinical adoption of EIVD 4m The role of EIVD in Online Adaptive Radiotherapy 4m Artificial intelligence for EIVD: from Research to Clinic How in-vivo dosimetri in brachytherapy progressed from being a measurement of dose to organs at risk to becoming a tool for treatment monitoring Current concepts and dosimeters for in-vivo dosimetry in brachytherapy: point dosimeters and 2D panels Requirements for in-vivo dosimetry in brachytherapy Limitations and challenges Future prospects: how do we transform from research to clinical application?
Symposium
Physics
Sunday
May 17
15:15 - 16:30
A10
Edmond Sterpin, Belgium;
Joachim Marichal, Belgium
Synergy is defined as the concept where a combined effect of two or more entities is greater than the sum of their individual effects. Radiation oncology is evolving rapidly and on several fronts; where these fronts intersect, synergy can emerge. These joint evolutions carry the potential to have a lasting impact in the field, such as IGRT, which is now widely adopted. In this session, topics covered will range from combining protons with photons or MR-Linacs to pairing conventional RT with theranostics or FLASH, and adaptive RT with functional imaging. Five European experts in the field pitch their research, addressing potential clinical benefits, technical challenges, and future prospects.
Pitch Session
Physics
Sunday
May 17
15:15 - 16:30
A12
Gunvor Dichmann Thyssen, Denmark;
Nicola Iosca, Italy
As radiotherapy evolves, a gap still exists between clinical intentions and patients' actual experiences. This session will explore how a true partnership between patients and professionals can reshape the field by integrating the patient’s voice. Key topics will address patient priorities, including effective communication, preparation for treatment, emotional support, and inclusive care. The landscape of co-creation in shared decision-making will be discussed, focusing on gaps between intention and practice. The symposium will consider how patient and public involvement (PPI) can be integrated into development strategies, highlighting its potential to bridge the gap and support more responsive, patient-centred services.
Symposium
RTT
Sunday
May 17
15:15 - 16:30
K1
Peter Niehoff, Germany;
Troels Hasselgren Lautrup, Denmark
In this symposium the focus will be on shared decision making in brachytherapy from both a clinical and a patient perspective. The session will first focus on the patients’ knowledge, and understanding on the topic of brachytherapy together with patient barriers for informed decision making. Afterwards the session will focus on the validation of existing shared-decision tools set in clinical scenarios from both a clinical and patient centred choice. Lastly a patient will share her personal experience with brachytherapy and with shared decision in that setting.
Symposium
Brachytherapy
Sunday
May 17
15:15 - 16:15
T2
Gerard Walls, United Kingdom;
Rafal Dziadziuszko, Poland
Mini-Orals
Clinical
Sunday
May 17
15:15 - 16:15
A6
Julia Thiele, ;
Lynsey Devlin, United Kingdom
Mini-Orals
RTT
Sunday
May 17
15:15 - 16:15
K2
Conor McGarry, United Kingdom
Poster Discussions
Physics
Sunday
May 17
15:15 - 16:15
K11
Ahmed Gawish, Germany;
Enis Ozyar, Turkey
Poster Discussions
Clinical
+(event:"efd886fc-e357-f011-bec1-6045bddff504")